Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The new DRG is a mixed payment method in which the NHIS pays for medical expenses incurred during a single medical treatment, dividing the cost of procedures, drugs, and therapeutic materials into all-inclusive and non-inclusive fees.
Most medical services are comprehensively bundled together, but high-value services that cause differences in medical expenses are paid independently. In this report, we have selected the most important aspects of this new system in regard to therapeutic materials.
The new DRG is the third type of payment model that has been introduced within the NHIS pricing structure. First, fee-for-service was introduced, then DRG, and finally the new DRG. Currently, these three payment models coexist and they are applied depending on the type of healthcare facilities and disease groups.
Fee-for-service is a system that divides the various services provided in the course of a single medical or surgical procedure into separate, predetermined amounts (e.g., anesthesia, surgical procedure, materials, medications, hospitalization, etc. used in a single surgery are paid separately).
The DRG system pays for the entire cost of a single surgery in one predetermined amount (e.g., one overall fee for a single surgery). Prior to the introduction of the new DRG, the NHIS was divided into two categories: those that were paid on a fee-for-service basis and those that were paid on a DRG basis under a single diagnosis.